Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19 | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

Respiratory infection

Original research

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Khan FA, Stewart I, Fabbri L, et al

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19

Thorax 2021;76:907-919.